Skip to main content
Top
Published in: BMC Cancer 1/2010

Open Access 01-12-2010 | Research article

Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway

Authors: Grethe Albrektsen, Ivar Heuch, Steinar Ø Thoresen

Published in: BMC Cancer | Issue 1/2010

Login to get access

Abstract

Background

Some studies have indicated that reproductive factors affect the risk of histological types of breast cancer differently. The long-term protective effect of a childbirth is preceded by a short-term adverse effect. Few studies have examined whether tumors diagnosed shortly after birth have specific histological characteristics.

Methods

In the present register-based study, comprising information for 22,867 Norwegian breast cancer cases (20-74 years), we examined whether histological type (9 categories) and grade of tumor (2 combined categories) differed by parity or age at first birth. Associations with time since birth were evaluated among 9709 women diagnosed before age 50 years. Chi-square tests were applied for comparing proportions, whereas odds ratios (each histological type vs. ductal, or grade 3-4 vs. grade 1-2) were estimated in polytomous and binary logistic regression analyses.

Results

Ductal tumors, the most common histological type, accounted for 81.4% of all cases, followed by lobular tumors (6.3%) and unspecified carcinomas (5.5%). Other subtypes accounted for 0.4%-1.5% of the cases each. For all histological types, the proportions differed significantly by age at diagnoses. The proportion of mucinous and tubular tumors decreased with increasing parity, whereas Paget disease and medullary tumors were most common in women of high parity. An increasing trend with increasing age at first birth was most pronounced for lobular tumors and unspecified carcinomas; an association in the opposite direction was seen in relation to medullary and tubular tumors. In age-adjusted analyses, only the proportions of unspecified carcinomas and lobular tumors decreased significantly with increasing time since first and last birth. However, ductal tumors, and malignant sarcomas, mainly phyllodes tumors, seemed to occur at higher frequency in women diagnosed <2 years after first childbirth. The proportions of medullary tumors and Paget disease were particularly high among women diagnosed 2-5 years after last birth. The high proportion of poorly differentiated tumors in women with a recent childbirth was partly explained by young age.

Conclusion

Our results support previous observations that reproductive factors affect the risk of histological types of breast cancer differently. Sarcomas, medullary tumors, and possible also Paget disease, may be particularly susceptible to pregnancy-related exposure.
Literature
1.
go back to reference Wohlfahrt J, Mouridsen H, Andersen PK, Melbye M: Reproductive risk factors for breast cancer by receptor status, histology, laterality and location. Int J Cancer. 1999, 81: 49-55. 10.1002/(SICI)1097-0215(19990331)81:1<49::AID-IJC10>3.0.CO;2-7.CrossRefPubMed Wohlfahrt J, Mouridsen H, Andersen PK, Melbye M: Reproductive risk factors for breast cancer by receptor status, histology, laterality and location. Int J Cancer. 1999, 81: 49-55. 10.1002/(SICI)1097-0215(19990331)81:1<49::AID-IJC10>3.0.CO;2-7.CrossRefPubMed
2.
go back to reference Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, Daling JR, Norman SA, Liff JM, Marchbanks PA, Folger SG, Simon MS, Strom BL, Burkman RT, Weiss LK, Spirtas R: Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer. 2005, 93: 364-371. 10.1038/sj.bjc.6602712.CrossRefPubMedPubMedCentral Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, Daling JR, Norman SA, Liff JM, Marchbanks PA, Folger SG, Simon MS, Strom BL, Burkman RT, Weiss LK, Spirtas R: Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer. 2005, 93: 364-371. 10.1038/sj.bjc.6602712.CrossRefPubMedPubMedCentral
3.
go back to reference Li CI, Daling JR, Malone KE, Bernstein L, Marchbanks PA, Liff JM, Strom BL, Simon MS, Press MF, McDonald JA, Ursin G, Burkman RT, Deapen D, Spirtas R: Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2006, 15: 946-954. 10.1158/1055-9965.EPI-05-0881.CrossRefPubMed Li CI, Daling JR, Malone KE, Bernstein L, Marchbanks PA, Liff JM, Strom BL, Simon MS, Press MF, McDonald JA, Ursin G, Burkman RT, Deapen D, Spirtas R: Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2006, 15: 946-954. 10.1158/1055-9965.EPI-05-0881.CrossRefPubMed
4.
go back to reference Reeves GK, Beral V, Green J, Gathani T, Bull D: Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta analysis. Lancet Oncol. 2006, 7: 910-18. 10.1016/S1470-2045(06)70911-1.CrossRefPubMed Reeves GK, Beral V, Green J, Gathani T, Bull D: Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta analysis. Lancet Oncol. 2006, 7: 910-18. 10.1016/S1470-2045(06)70911-1.CrossRefPubMed
5.
go back to reference Rosenberg LU, Magnusson C, Lindström E, Wedrén S, Hall P, Dickman PW: Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case control study. Breast Cancer Res. 2006, 8: R11-10.1186/bcr1378.CrossRefPubMedPubMedCentral Rosenberg LU, Magnusson C, Lindström E, Wedrén S, Hall P, Dickman PW: Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case control study. Breast Cancer Res. 2006, 8: R11-10.1186/bcr1378.CrossRefPubMedPubMedCentral
6.
go back to reference Beaber EF, Holt VL, Malone KE, Porter PL, Daling JR, Li CI: Reproductive factors, age at maximum height, and risk of three histologic types of breast cancer. Cancer Epidemiol Biomarkers Prev. 2008, 17: 3427-3434. 10.1158/1055-9965.EPI-08-0641.CrossRefPubMedPubMedCentral Beaber EF, Holt VL, Malone KE, Porter PL, Daling JR, Li CI: Reproductive factors, age at maximum height, and risk of three histologic types of breast cancer. Cancer Epidemiol Biomarkers Prev. 2008, 17: 3427-3434. 10.1158/1055-9965.EPI-08-0641.CrossRefPubMedPubMedCentral
7.
go back to reference Reeves GK, Pirie K, Green J, Bull D, Beral V: Reproductive factors and specific histological types of breast cancer: a prospective study and meta-analysis. Br J Cancer. 2009, 100: 538-544. 10.1038/sj.bjc.6604853.CrossRefPubMedPubMedCentral Reeves GK, Pirie K, Green J, Bull D, Beral V: Reproductive factors and specific histological types of breast cancer: a prospective study and meta-analysis. Br J Cancer. 2009, 100: 538-544. 10.1038/sj.bjc.6604853.CrossRefPubMedPubMedCentral
8.
go back to reference Pathak DR: Dual effect of first full term pregnancy on breast cancer risk: empirical evidence and postulated underlying biology. Cancer Causes Control. 2002, 13: 295-298. 10.1023/A:1015282916368.CrossRefPubMed Pathak DR: Dual effect of first full term pregnancy on breast cancer risk: empirical evidence and postulated underlying biology. Cancer Causes Control. 2002, 13: 295-298. 10.1023/A:1015282916368.CrossRefPubMed
9.
go back to reference Albrektsen G, Heuch I, Hansen S, Kvåle G: Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer. 2005, 92: 167-175. 10.1038/sj.bjc.6602302.CrossRefPubMed Albrektsen G, Heuch I, Hansen S, Kvåle G: Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer. 2005, 92: 167-175. 10.1038/sj.bjc.6602302.CrossRefPubMed
10.
go back to reference Lethaby AE, O'Neill MA, Mason BH, Holdaway IM, Harvey VJ: Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Int J Cancer. 1996, 67: 751-755. 10.1002/(SICI)1097-0215(19960917)67:6<751::AID-IJC1>3.0.CO;2-Q.CrossRefPubMed Lethaby AE, O'Neill MA, Mason BH, Holdaway IM, Harvey VJ: Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Int J Cancer. 1996, 67: 751-755. 10.1002/(SICI)1097-0215(19960917)67:6<751::AID-IJC1>3.0.CO;2-Q.CrossRefPubMed
11.
go back to reference Keleher AJ, Theriault RL, Gwyn KM, Hunt KK, Stelling CB, Singletary E, Ames FC, Buchholz TA, Sahin AA, Kuerer HM: Multidisciplinary management of breast cancer concurrent with pregnancy. J Am Coll Surg. 2001, 194: 54-64. 10.1016/S1072-7515(01)01105-X.CrossRef Keleher AJ, Theriault RL, Gwyn KM, Hunt KK, Stelling CB, Singletary E, Ames FC, Buchholz TA, Sahin AA, Kuerer HM: Multidisciplinary management of breast cancer concurrent with pregnancy. J Am Coll Surg. 2001, 194: 54-64. 10.1016/S1072-7515(01)01105-X.CrossRef
12.
go back to reference Woo JC, Yu T, Hurd TC: Breast cancer in pregnancy. A literature review. Arch Surg. 2003, 138: 91-98. 10.1001/archsurg.138.1.91.CrossRefPubMed Woo JC, Yu T, Hurd TC: Breast cancer in pregnancy. A literature review. Arch Surg. 2003, 138: 91-98. 10.1001/archsurg.138.1.91.CrossRefPubMed
13.
go back to reference Phillips KA, Milne RL, Friedlander ML, Jenkins MA, McCredie MRE, Giles GG, Hopper JL: Prognosis of premenopausal breast cancer and childbirth prior to diagnosis. J Clin Oncol. 2004, 22: 699-705. 10.1200/JCO.2004.07.062.CrossRefPubMed Phillips KA, Milne RL, Friedlander ML, Jenkins MA, McCredie MRE, Giles GG, Hopper JL: Prognosis of premenopausal breast cancer and childbirth prior to diagnosis. J Clin Oncol. 2004, 22: 699-705. 10.1200/JCO.2004.07.062.CrossRefPubMed
14.
go back to reference Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de Las Heras P, Lerma E: Radiologic evaluation of breast disorders related to pregnancy and lactation. RG. 2007, 27: S101-S124.CrossRef Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de Las Heras P, Lerma E: Radiologic evaluation of breast disorders related to pregnancy and lactation. RG. 2007, 27: S101-S124.CrossRef
15.
go back to reference Daling JR, Malone KE, Doody DR, Anderson BO, Porter PL: The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol Biomarkers Prev. 2002, 11: 235-241.PubMed Daling JR, Malone KE, Doody DR, Anderson BO, Porter PL: The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol Biomarkers Prev. 2002, 11: 235-241.PubMed
16.
go back to reference Kroman N, Mouridsen HT: Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer. Breast. 2003, 12: 516-521. 10.1016/S0960-9776(03)00159-0.CrossRefPubMed Kroman N, Mouridsen HT: Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer. Breast. 2003, 12: 516-521. 10.1016/S0960-9776(03)00159-0.CrossRefPubMed
17.
go back to reference Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA: Reproductive history and mortality after breast cancer diagnosis. Obstet Gynecol. 2004, 104: 146-154.CrossRefPubMed Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA: Reproductive history and mortality after breast cancer diagnosis. Obstet Gynecol. 2004, 104: 146-154.CrossRefPubMed
18.
go back to reference Ibrahim EM, Ezzat AA, Baloush A, Hussain ZH, Mohammed GH: Pregnancy-associated breast cancer: a case-control study in a young population with a high-fertility rate. Med Oncol. 2000, 17: 293-300. 10.1007/BF02782194.CrossRefPubMed Ibrahim EM, Ezzat AA, Baloush A, Hussain ZH, Mohammed GH: Pregnancy-associated breast cancer: a case-control study in a young population with a high-fertility rate. Med Oncol. 2000, 17: 293-300. 10.1007/BF02782194.CrossRefPubMed
19.
go back to reference Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A: Breast carcinoma in pregnant women. Assessment of clinicopathologic and immunohistochemical features. Cancer. 2003, 98: 1055-1060. 10.1002/cncr.11614.CrossRefPubMed Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A: Breast carcinoma in pregnant women. Assessment of clinicopathologic and immunohistochemical features. Cancer. 2003, 98: 1055-1060. 10.1002/cncr.11614.CrossRefPubMed
20.
go back to reference Largent JA, Ziogas A, Anton-Culver H: Effect of reproductive factors on stage, grade and hormone receptor status in early-onset breast cancer. Breast Cancer Res. 2005, 7: R541-R554. 10.1186/bcr1198.CrossRefPubMedPubMedCentral Largent JA, Ziogas A, Anton-Culver H: Effect of reproductive factors on stage, grade and hormone receptor status in early-onset breast cancer. Breast Cancer Res. 2005, 7: R541-R554. 10.1186/bcr1198.CrossRefPubMedPubMedCentral
21.
go back to reference Albrektsen G, Heuch I, Thoresen S, Kvåle G: Clinical stage of breast cancer by parity, age at birth, and time since birth: a progressive effect of pregnancy hormones?. Cancer Epidemiol Biomarkers Prev. 2006, 15: 65-69. 10.1158/1055-9965.EPI-05-0634.CrossRefPubMed Albrektsen G, Heuch I, Thoresen S, Kvåle G: Clinical stage of breast cancer by parity, age at birth, and time since birth: a progressive effect of pregnancy hormones?. Cancer Epidemiol Biomarkers Prev. 2006, 15: 65-69. 10.1158/1055-9965.EPI-05-0634.CrossRefPubMed
22.
go back to reference Allemani C, Sant M, Berrino F, Aareleid T, Chaplain G, Coebergh JW, Colonna M, Contiero P, Danzon A, Federico M, Gafà L, Grosclaude P, Hédelin G, Macè-Lesech J, Garcia CM, Paci E, Raverdy N, Tretarre B, Williams EMI: Prognostic value of morphology and hormone receptor status in breast cancer - a population-based study. Br J Cancer. 2004, 91: 1263-1268. 10.1038/sj.bjc.6602153.CrossRefPubMedPubMedCentral Allemani C, Sant M, Berrino F, Aareleid T, Chaplain G, Coebergh JW, Colonna M, Contiero P, Danzon A, Federico M, Gafà L, Grosclaude P, Hédelin G, Macè-Lesech J, Garcia CM, Paci E, Raverdy N, Tretarre B, Williams EMI: Prognostic value of morphology and hormone receptor status in breast cancer - a population-based study. Br J Cancer. 2004, 91: 1263-1268. 10.1038/sj.bjc.6602153.CrossRefPubMedPubMedCentral
23.
go back to reference Li CI, Uribe DJ, Daling JR: Clinical characteristics of different histologic types of breast cancer. Br J Cancer. 2005, 93: 1046-1052. 10.1038/sj.bjc.6602787.CrossRefPubMedPubMedCentral Li CI, Uribe DJ, Daling JR: Clinical characteristics of different histologic types of breast cancer. Br J Cancer. 2005, 93: 1046-1052. 10.1038/sj.bjc.6602787.CrossRefPubMedPubMedCentral
24.
go back to reference Gallager HS: Pathologic types of breast cancer: their prognoses. Cancer. 1984, 53: 623-629. 10.1002/1097-0142(19840201)53:3+<623::AID-CNCR2820531307>3.0.CO;2-Z.CrossRefPubMed Gallager HS: Pathologic types of breast cancer: their prognoses. Cancer. 1984, 53: 623-629. 10.1002/1097-0142(19840201)53:3+<623::AID-CNCR2820531307>3.0.CO;2-Z.CrossRefPubMed
25.
go back to reference Linell F, Tengrup I, Tennvall-Nittby L, Landberg T: Modified histologic classification for carcinoma of the breast. Prognostic value and relation to effect of adjuvant oophorectomy. Acta Oncol. 1987, 26: 343-348. 10.3109/02841868709104358.CrossRefPubMed Linell F, Tengrup I, Tennvall-Nittby L, Landberg T: Modified histologic classification for carcinoma of the breast. Prognostic value and relation to effect of adjuvant oophorectomy. Acta Oncol. 1987, 26: 343-348. 10.3109/02841868709104358.CrossRefPubMed
26.
go back to reference Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A: Tumour development, histology and grade of breast cancer: prognosis and progression. Int J Cancer. 1996, 66: 413-419. 10.1002/(SICI)1097-0215(19960516)66:4<413::AID-IJC1>3.0.CO;2-Z.CrossRefPubMed Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A: Tumour development, histology and grade of breast cancer: prognosis and progression. Int J Cancer. 1996, 66: 413-419. 10.1002/(SICI)1097-0215(19960516)66:4<413::AID-IJC1>3.0.CO;2-Z.CrossRefPubMed
27.
go back to reference Louwman MWJ, Vriezen M, van Beek MWPN, Nolthenius-Puylaert CBJET, Sangen van der MJC, Roumen RM, Kiemeney LALM, Coebergh JWW: Uncommon breast tumors in perspective: Incidence, treatment and survival in the Netherlands. Int J Cancer. 2007, 121: 127-135. 10.1002/ijc.22625.CrossRefPubMed Louwman MWJ, Vriezen M, van Beek MWPN, Nolthenius-Puylaert CBJET, Sangen van der MJC, Roumen RM, Kiemeney LALM, Coebergh JWW: Uncommon breast tumors in perspective: Incidence, treatment and survival in the Netherlands. Int J Cancer. 2007, 121: 127-135. 10.1002/ijc.22625.CrossRefPubMed
28.
go back to reference Albrektsen G, Heuch I, Thoresen S, Kvåle G: Family history of breast cancer and short-term effects of childbirths on breast cancer risk. Int J Cancer. 2006, 119: 1468-1474. 10.1002/ijc.22003.CrossRefPubMed Albrektsen G, Heuch I, Thoresen S, Kvåle G: Family history of breast cancer and short-term effects of childbirths on breast cancer risk. Int J Cancer. 2006, 119: 1468-1474. 10.1002/ijc.22003.CrossRefPubMed
29.
go back to reference Anderson WF, Pfeiffer RM, Dores GM, Sherman ME: Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev. 2006, 15: 1899-1905. 10.1158/1055-9965.EPI-06-0191.CrossRefPubMed Anderson WF, Pfeiffer RM, Dores GM, Sherman ME: Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev. 2006, 15: 1899-1905. 10.1158/1055-9965.EPI-06-0191.CrossRefPubMed
30.
go back to reference Zagouri F, Sergentanis TN, Zografos GC: Precursor and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma. World J Surg Oncol. 2007, 5: 57-10.1186/1477-7819-5-57.CrossRefPubMedPubMedCentral Zagouri F, Sergentanis TN, Zografos GC: Precursor and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma. World J Surg Oncol. 2007, 5: 57-10.1186/1477-7819-5-57.CrossRefPubMedPubMedCentral
31.
go back to reference Weedon-Fekjær H, Lindqvist BH, Vatten LJ, Aalen OO, Tretli S: Breast cancer tumor growth estimated through mammography screening data. Breast Cancer Res. 2008, 10: R41-10.1186/bcr2092.CrossRefPubMedPubMedCentral Weedon-Fekjær H, Lindqvist BH, Vatten LJ, Aalen OO, Tretli S: Breast cancer tumor growth estimated through mammography screening data. Breast Cancer Res. 2008, 10: R41-10.1186/bcr2092.CrossRefPubMedPubMedCentral
32.
go back to reference Meeske K, Press M, Patel A, Bernstein L: Impact of reproductive factors and lactation on breast carcinoma in situ risk. Int J Cancer. 2004, 110: 102-109. 10.1002/ijc.20072.CrossRefPubMed Meeske K, Press M, Patel A, Bernstein L: Impact of reproductive factors and lactation on breast carcinoma in situ risk. Int J Cancer. 2004, 110: 102-109. 10.1002/ijc.20072.CrossRefPubMed
33.
go back to reference Simpson SA, Redstone J, Aziz MS, Bernik SF: Large malignant phyllodes tumor with rapid growth during pregnancy: images of a case. Breast J. 2007, 13: 620-621. 10.1111/j.1524-4741.2007.00500.x.CrossRefPubMed Simpson SA, Redstone J, Aziz MS, Bernik SF: Large malignant phyllodes tumor with rapid growth during pregnancy: images of a case. Breast J. 2007, 13: 620-621. 10.1111/j.1524-4741.2007.00500.x.CrossRefPubMed
34.
go back to reference Grabowski J, Salzstein SL, Sadler GR, Blair SL: Malignant phyllodes tumors: review of 752 cases. Am Surg. 2007, 73: 967-969.PubMed Grabowski J, Salzstein SL, Sadler GR, Blair SL: Malignant phyllodes tumors: review of 752 cases. Am Surg. 2007, 73: 967-969.PubMed
35.
go back to reference Pezner RD, Schultheiss TE, Paz IB: Malignant phyllodes tumor of the breast: local control rates with surgery alone. Int J Radiation Oncology Biol Phys. 2008, 71: 710-713.CrossRef Pezner RD, Schultheiss TE, Paz IB: Malignant phyllodes tumor of the breast: local control rates with surgery alone. Int J Radiation Oncology Biol Phys. 2008, 71: 710-713.CrossRef
36.
go back to reference Taira N, Takabatake D, Aogi K, Ohsumi S, Takashima S, Nishimura R, Teramoto N: Phyllodes tumor of the breast: Stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin. Jpn J Clin Oncol. 2007, 37: 730-736. 10.1093/jjco/hym099.CrossRefPubMed Taira N, Takabatake D, Aogi K, Ohsumi S, Takashima S, Nishimura R, Teramoto N: Phyllodes tumor of the breast: Stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin. Jpn J Clin Oncol. 2007, 37: 730-736. 10.1093/jjco/hym099.CrossRefPubMed
37.
go back to reference Erdreich LS, Asal NR, Hoge AF: Morphologic types of breast cancer: age, bilaterality, and family history. South Med J. 1980, 73: 28-32.CrossRefPubMed Erdreich LS, Asal NR, Hoge AF: Morphologic types of breast cancer: age, bilaterality, and family history. South Med J. 1980, 73: 28-32.CrossRefPubMed
38.
go back to reference Marcus JN, Watson P, Page DL, Lynch HT: Pathology and heredity of breast cancer in younger women. Monogr Natl Cancer Inst. 1994, 16: 23-34.PubMed Marcus JN, Watson P, Page DL, Lynch HT: Pathology and heredity of breast cancer in younger women. Monogr Natl Cancer Inst. 1994, 16: 23-34.PubMed
39.
go back to reference Claus EB, Risch N, Thomson WD, Carter D: Relationship between breast histopathology and family history of breast cancer. Cancer. 1993, 71: 147-153. 10.1002/1097-0142(19930101)71:1<147::AID-CNCR2820710124>3.0.CO;2-V.CrossRefPubMed Claus EB, Risch N, Thomson WD, Carter D: Relationship between breast histopathology and family history of breast cancer. Cancer. 1993, 71: 147-153. 10.1002/1097-0142(19930101)71:1<147::AID-CNCR2820710124>3.0.CO;2-V.CrossRefPubMed
40.
go back to reference Allen-Brady K, Camp NJ, Ward JH, Cannon-Albright LA: Lobular breast cancer: Excess familiality observed in the Utah population database. Int J Cancer. 2005, 117: 655-661. 10.1002/ijc.21236.CrossRefPubMed Allen-Brady K, Camp NJ, Ward JH, Cannon-Albright LA: Lobular breast cancer: Excess familiality observed in the Utah population database. Int J Cancer. 2005, 117: 655-661. 10.1002/ijc.21236.CrossRefPubMed
41.
go back to reference Pedersen L, Zedeler K, Holck S, Schiødt T, Mouridsen HT: Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer. Eur J Cancer. 1995, 31A: 2289-2295. 10.1016/0959-8049(95)00408-4.CrossRefPubMed Pedersen L, Zedeler K, Holck S, Schiødt T, Mouridsen HT: Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer. Eur J Cancer. 1995, 31A: 2289-2295. 10.1016/0959-8049(95)00408-4.CrossRefPubMed
42.
go back to reference Yakirevich E, Izhak OB, Rennert G, Kovacs ZG, Resnick MB: Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast. Mod Pathol. 1999, 12: 1050-1056.PubMed Yakirevich E, Izhak OB, Rennert G, Kovacs ZG, Resnick MB: Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast. Mod Pathol. 1999, 12: 1050-1056.PubMed
43.
go back to reference Jacquemier J, Padovani L, Rabayrol L, Lakhani SR, Penault-Llorca F, Denoux Y, Fiche M, Figueiro P, Maisongrosse V, Ledoussal V, Penuela JM, Udvarhely N, Makdissi GE, Ginestier C, Geneix J, Charafe-Jauffret E, Xerri L, Eisinger F, Birnbaum D: Typical medullary breast carcinomas have a basal/myoepithelial phenotype. J Pathol. 2005, 207: 260-268. 10.1002/path.1845.CrossRefPubMed Jacquemier J, Padovani L, Rabayrol L, Lakhani SR, Penault-Llorca F, Denoux Y, Fiche M, Figueiro P, Maisongrosse V, Ledoussal V, Penuela JM, Udvarhely N, Makdissi GE, Ginestier C, Geneix J, Charafe-Jauffret E, Xerri L, Eisinger F, Birnbaum D: Typical medullary breast carcinomas have a basal/myoepithelial phenotype. J Pathol. 2005, 207: 260-268. 10.1002/path.1845.CrossRefPubMed
44.
go back to reference Breast Cancer Linkage Consortium: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 and BRCA2 mutations and sporadic cancer. Lancet. 1997, 349: 1505-1510. 10.1016/S0140-6736(96)10109-4.CrossRef Breast Cancer Linkage Consortium: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 and BRCA2 mutations and sporadic cancer. Lancet. 1997, 349: 1505-1510. 10.1016/S0140-6736(96)10109-4.CrossRef
45.
go back to reference Chen CY, Sun LM, Anderson BO: Paget disease of the breast: changing patterns of incidence, clinical presentation, and treatment in the US. Cancer. 2006, 107: 1448-1458. 10.1002/cncr.22137.CrossRefPubMed Chen CY, Sun LM, Anderson BO: Paget disease of the breast: changing patterns of incidence, clinical presentation, and treatment in the US. Cancer. 2006, 107: 1448-1458. 10.1002/cncr.22137.CrossRefPubMed
46.
go back to reference Brunhuber T, Haybaeck J, Schäfer G, Mikuz G, Langhoff E, Saeland Lebecque S, Romani N, Obrist P: Immunohistochemical tracking of an immune response in mammary Paget's disease. Cancer Lett. 2008, 272: 206-220. 10.1016/j.canlet.2008.07.028.CrossRefPubMed Brunhuber T, Haybaeck J, Schäfer G, Mikuz G, Langhoff E, Saeland Lebecque S, Romani N, Obrist P: Immunohistochemical tracking of an immune response in mammary Paget's disease. Cancer Lett. 2008, 272: 206-220. 10.1016/j.canlet.2008.07.028.CrossRefPubMed
47.
go back to reference Fu W, Lobocki CA, Silberberg BK, Chelladurai M, Young SC: Molecular markers in Paget disease of the breast. J Surg Oncol. 2001, 77: 171-178. 10.1002/jso.1090.CrossRefPubMed Fu W, Lobocki CA, Silberberg BK, Chelladurai M, Young SC: Molecular markers in Paget disease of the breast. J Surg Oncol. 2001, 77: 171-178. 10.1002/jso.1090.CrossRefPubMed
48.
go back to reference McDaniel SM, Rumer KK, Biroc SL, Metz RP, Singh M, Porter W, Schedin P: Remodeling of the mammary microenvironment after lactation promotes tumor cell metastasis. Am J Pathol. 2006, 168: 608-620. 10.2353/ajpath.2006.050677.CrossRefPubMedPubMedCentral McDaniel SM, Rumer KK, Biroc SL, Metz RP, Singh M, Porter W, Schedin P: Remodeling of the mammary microenvironment after lactation promotes tumor cell metastasis. Am J Pathol. 2006, 168: 608-620. 10.2353/ajpath.2006.050677.CrossRefPubMedPubMedCentral
49.
go back to reference Schedin P, O'Brien J, Rudolph M, Stein T, Borges V: Microenvironment of the involuting mammary gland mediates mammary cancer progression. J Mammary Gland Biol Neoplasia. 2007, 12: 71-82. 10.1007/s10911-007-9039-3.CrossRefPubMed Schedin P, O'Brien J, Rudolph M, Stein T, Borges V: Microenvironment of the involuting mammary gland mediates mammary cancer progression. J Mammary Gland Biol Neoplasia. 2007, 12: 71-82. 10.1007/s10911-007-9039-3.CrossRefPubMed
50.
51.
go back to reference Veneroso C, Siegel R, Levine PH: Early age at first childbirth associated with advanced tumor grade in breast cancer. Cancer Detect Prev. 2008, 32: 215-223. 10.1016/j.cdp.2008.04.001.CrossRefPubMed Veneroso C, Siegel R, Levine PH: Early age at first childbirth associated with advanced tumor grade in breast cancer. Cancer Detect Prev. 2008, 32: 215-223. 10.1016/j.cdp.2008.04.001.CrossRefPubMed
Metadata
Title
Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway
Authors
Grethe Albrektsen
Ivar Heuch
Steinar Ø Thoresen
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2010
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-10-226

Other articles of this Issue 1/2010

BMC Cancer 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine